[Skip to Content]
[Skip to Content Landing]
October 25, 1976

Influenza Vaccination in Patients With Multiple Sclerosis

Author Affiliations

From the Department of Neurology, University of Arizona College of Medicine and University Hospital, Tucson.

JAMA. 1976;236(17):1965-1966. doi:10.1001/jama.1976.03270180041018

Vaccination was well tolerated by 93 patients with multiple sclerosis who received a total of 209 doses of influenza vaccine. In one patient, evidence of a new lesion developed after vaccination; the relapse rate was less than would be expected in the natural course of the illness. Toxic and allergic reactions appeared with 7% and 0.5% of the vaccinations, respectively—a rate no higher than that observed in the general population.

(JAMA 236:1965-1966, 1976)